Clinical Trial

A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO

Name: A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO — clinical trial record (NCT07734844)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ALTO

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants with Diabetic Macular Edema - ALTO

Trial Details

NCT Number	NCT07734844
Lead Sponsor	Kodiak Sciences Inc
Conditions	Diabetic Macular Edema (DME)
Enrollment	910 participants
Start Date	2026-08
Primary Completion	2028-08 (estimated)
Study Completion	2029-08 (estimated)
Updated on ClinicalTrials.gov	2026-07-29